RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug
Xconomy
MAY 30, 2017
San Diego-based Arcturus Therapeutics said today Cystic Fibrosis Foundation Therapeutics has agreed to provide $3 million to fund research and development of a new messenger RNA drug that could be broadly used to treat cystic fibrosis patients. Arcturus says its technology can be used to make.
65 
Let's personalize your content